https://stock.noler.com/us/stock/global-immune-technologies-inc https://stock.noler.com/us/stock/global-immune-technologies-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/global-immune-technologies-inc/accounts-receivable https://stock.noler.com/us/stock/global-immune-technologies-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/global-immune-technologies-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/global-immune-technologies-inc/amended-reports-20-f https://stock.noler.com/us/stock/global-immune-technologies-inc/amortization-of-deferred-charges https://stock.noler.com/us/stock/global-immune-technologies-inc/aoci https://stock.noler.com/us/stock/global-immune-technologies-inc/cash-and-equivalents https://stock.noler.com/us/stock/global-immune-technologies-inc/cash-flow-breakdown https://stock.noler.com/us/stock/global-immune-technologies-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/global-immune-technologies-inc/common-stock-share-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/global-immune-technologies-inc/common-stock-value https://stock.noler.com/us/stock/global-immune-technologies-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/global-immune-technologies-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/global-immune-technologies-inc/current-assets https://stock.noler.com/us/stock/global-immune-technologies-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/global-immune-technologies-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/global-immune-technologies-inc/current-liabilities https://stock.noler.com/us/stock/global-immune-technologies-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/global-immune-technologies-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/global-immune-technologies-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/global-immune-technologies-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/global-immune-technologies-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/global-immune-technologies-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/global-immune-technologies-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/global-immune-technologies-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/global-immune-technologies-inc/due-from-employees https://stock.noler.com/us/stock/global-immune-technologies-inc/due-from-employees-current https://stock.noler.com/us/stock/global-immune-technologies-inc/due-to-employees-current https://stock.noler.com/us/stock/global-immune-technologies-inc/due-to-related-parties-current https://stock.noler.com/us/stock/global-immune-technologies-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/global-immune-technologies-inc/effective-tax-rate https://stock.noler.com/us/stock/global-immune-technologies-inc/extinguishment-of-debt-amount https://stock.noler.com/us/stock/global-immune-technologies-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/global-immune-technologies-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/global-immune-technologies-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/global-immune-technologies-inc/financing-cash-flow https://stock.noler.com/us/stock/global-immune-technologies-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/global-immune-technologies-inc/form-d-other https://stock.noler.com/us/stock/global-immune-technologies-inc/general-and-administrative-expense https://stock.noler.com/us/stock/global-immune-technologies-inc/income-loss-from https://stock.noler.com/us/stock/global-immune-technologies-inc/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/global-immune-technologies-inc/income-taxes-paid https://stock.noler.com/us/stock/global-immune-technologies-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/global-immune-technologies-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/global-immune-technologies-inc/increase-decrease-in-due-from-employee-current https://stock.noler.com/us/stock/global-immune-technologies-inc/increase-decrease-in-due-to-employees-current https://stock.noler.com/us/stock/global-immune-technologies-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/global-immune-technologies-inc/insider-transactions-warrants https://stock.noler.com/us/stock/global-immune-technologies-inc/interest-expense https://stock.noler.com/us/stock/global-immune-technologies-inc/interest-paid-net https://stock.noler.com/us/stock/global-immune-technologies-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/global-immune-technologies-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/global-immune-technologies-inc/late-filing-notices-nt-20-f https://stock.noler.com/us/stock/global-immune-technologies-inc/lease-and-rental-expense https://stock.noler.com/us/stock/global-immune-technologies-inc/net-change-in-cash https://stock.noler.com/us/stock/global-immune-technologies-inc/net-income https://stock.noler.com/us/stock/global-immune-technologies-inc/notes-payable-current https://stock.noler.com/us/stock/global-immune-technologies-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/global-immune-technologies-inc/operating-cash-flow https://stock.noler.com/us/stock/global-immune-technologies-inc/operating-income https://stock.noler.com/us/stock/global-immune-technologies-inc/other-amortization-of-deferred-charges https://stock.noler.com/us/stock/global-immune-technologies-inc/other-deferred-cost-amortization-expense https://stock.noler.com/us/stock/global-immune-technologies-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/global-immune-technologies-inc/payments-for-legal-settlements https://stock.noler.com/us/stock/global-immune-technologies-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/global-immune-technologies-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/global-immune-technologies-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/global-immune-technologies-inc/proceeds-from-other-debt https://stock.noler.com/us/stock/global-immune-technologies-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/global-immune-technologies-inc/professional-fees https://stock.noler.com/us/stock/global-immune-technologies-inc/profit-loss https://stock.noler.com/us/stock/global-immune-technologies-inc/public-float https://stock.noler.com/us/stock/global-immune-technologies-inc/retained-earnings https://stock.noler.com/us/stock/global-immune-technologies-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/global-immune-technologies-inc/sec-filings-10-k https://stock.noler.com/us/stock/global-immune-technologies-inc/sec-filings-10-q https://stock.noler.com/us/stock/global-immune-technologies-inc/sec-filings-10ksb https://stock.noler.com/us/stock/global-immune-technologies-inc/sec-filings-10qsb https://stock.noler.com/us/stock/global-immune-technologies-inc/sec-filings-20-f https://stock.noler.com/us/stock/global-immune-technologies-inc/sec-filings-6-k https://stock.noler.com/us/stock/global-immune-technologies-inc/sec-filings-8-k https://stock.noler.com/us/stock/global-immune-technologies-inc/sec-filings-pre-14c https://stock.noler.com/us/stock/global-immune-technologies-inc/sec-filings-revoked https://stock.noler.com/us/stock/global-immune-technologies-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/global-immune-technologies-inc/shareholders-equity https://stock.noler.com/us/stock/global-immune-technologies-inc/shares-authorized https://stock.noler.com/us/stock/global-immune-technologies-inc/shares-issued https://stock.noler.com/us/stock/global-immune-technologies-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/global-immune-technologies-inc/shares-outstanding-2 https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-issued-shares-issued-shares-reverse-stock-splits https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/global-immune-technologies-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/global-immune-technologies-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/global-immune-technologies-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/global-immune-technologies-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/global-immune-technologies-inc/total-assets https://stock.noler.com/us/stock/global-immune-technologies-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/global-immune-technologies-inc/translation-adjustment-functional-to-reporting-currency-net-of-tax-change https://stock.noler.com/us/stock/global-immune-technologies-inc/travel-and-entertainment-expense https://stock.noler.com/us/stock/global-immune-technologies-inc/weighted-average-number-of-share-outstanding-basic-and-diluted